Gene Query: RIOK2

Dataset Description Geneva Score
SLAM-seq for K562 endogenous mRNA decay 22.3
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 18.92
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 17.93
R430: A potent inbibitor of DNA and RNA viruses 17.27
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 15.26
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 12.54
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 12.44
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 11.68
RNAseq Study in CC-671 Treated Cal-51 Cells 11.63
Cleavage Factor Im as a key regulator of 3’ UTR length 11.06
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 10.91
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 10.18
ETV7 and interferon response 9.92
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 9.92
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 9.67
single cell RNA-seq from GM12878 (ENCSR673UIY) 9.29
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 8.94
RNA-seq in transgenic cells 8.74
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 8.58
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 8.24
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 8.19
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.95
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 7.92
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 7.6
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 7.47
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 7.45
A transcriptome-wide divergence in protein translation scales with LIN28B expression 7.45
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 7.43
TCF7L1 knockdown in pancreatic cancer 7.33
Differentially expressed genes post knock down of lincDUSP26 7.06
Tracking of dCas9-methyltransferase footprints 6.97
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 6.94
SETBP1-WT and SETBP1-G870S epigenetic landscapes 6.94
Gene expression in PANC1 cells treated with Rakicidin 6.89
DRB/GRO-Seq -/+ UV 6.82
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 6.81
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 6.74
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.51
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 6.5
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 6.5
Cell responses to dysregulated VZV-induced cell-cell fusion 6.5
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 6.31
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 6.31
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.21
DART-seq: an antibody-free method for global m6A detection 6.12
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.04
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 6.04
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 5.95
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 5.95
Gene expression analysis of dengue-infected cells 5.93
Regulation of protein translation during mitosis 5.76
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.72
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 5.69
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 5.67
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 5.65
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 5.62
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 5.62
Total RNA-seq in ALL-SIL upon TLX1 knockdown 5.61
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 5.56
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 5.55
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 5.5
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.44
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 5.37
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.28
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 5.28
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 5.27
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 5.18
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 5.16
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 5.15
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 5.14
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 5.08
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.05
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 5.03
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 5.03
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 4.99
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 4.98
Seletive inhibition of CDK9 in DLBCL cell lines 4.95
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 4.95
Genome wide miR-191 target profile determined by RIP and gene expression profiling 4.95
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 4.92
Landscape of H3K4me3 in human CD19 cells 4.83
Effect of BB608 on Gene Expression in HNSCC Cell Line 4.82
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 4.75
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 4.74
Developmental stage specific chromosome architecture in human erythroid cells 4.74
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 4.74
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 4.72
Comprehensive comparative analysis of 5’ end RNA sequencing methods 4.65
mRNA expression profile of Lymphocytes 4.6
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.59
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 4.56
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 4.55
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 4.54
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 4.52
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 4.52
MYC dependent mRNA translation shapes gene expression and cell biology 4.5
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 4.49
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 4.49
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 4.46
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.41
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 4.37
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 4.35
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.34
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 4.34
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 4.31
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 4.26
IL-33 activates tumor stroma to promote intestinal polyposis 4.23
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 4.23
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 4.23
Genome-wide discovery of human splicing branchpoints 4.22
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 4.22
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 4.21
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 4.17
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 4.13
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 4.04
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 4.04
RNA sequencing of BT142 and TS603 cell lines 3.99
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 3.99
MOF acetyl transferase regulates transcription and respiration in mitochondria 3.91
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 3.89
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 3.89
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 3.88
RNAseq analysis of ESRP regulated splicing events in prostate cancer 3.87
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 3.84
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 3.8
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 3.8
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.79
Polarized B -cell functions 3.78
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 3.76
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 3.75
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 3.75
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 3.74
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.73
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 3.71
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 3.69
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.68
Human cell line and subcutaneous tumor 3.63
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 3.59
Transcriptome analysis in Neobractatin treated cells 3.58
Hijacking of stress response machinery by oncogenes in acute leukaemia 3.58
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 3.58
Human embryonic stem cells in E8 and AKIT culture medium 3.58
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 3.58
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.58
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 3.55
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.54
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 3.54
JunB control of keratinocyte-mediated inflammation [RNA-seq] 3.54
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 3.49
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 3.48
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 3.48
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.46
UV_24h_GRO-Seq 3.4
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 3.38
Gene expression signatures of innate lymphoid cells from human blood 3.38
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 3.37
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 3.37
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.36
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.35
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 3.33
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 3.32
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 3.31
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 3.31
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 3.3
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 3.29
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 3.28
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 3.26
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 3.26
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 3.24
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.23
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 3.22
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.19
RNA-Seq with and without RNase treatment in PCa cell lines 3.18
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 3.18
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 3.18
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 3.17
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.17
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.17
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 3.13
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 3.11
Uridylation by TUT4 and TUT7 marks mRNA for degradation 3.11
RNA-seq analyisis of PUM2 knockout cells 3.1
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 3.07
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 3.07
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 3.04
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 3.04
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 3.03
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.02
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.01
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 2.98
RNA-seq of tumor cells following angiopellosis extravasation 2.97
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 2.94
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 2.93
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 2.91
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 2.91
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.88
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.88
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 2.88
UBC9 knockdown in bladder cancer T24 cell lines 2.87
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 2.87
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 2.82
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 2.82
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 2.81
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.79
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.77
Single-cell analysis of adult human ovary using 10X genomics 2.77
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.77
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.75
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.74
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.74
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 2.72
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 2.72
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 2.71
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 2.71
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.71
RNA-seq analysis of control and Myc-induced U2OS cells 2.69
Gene expression profile in breast cancer cells 2.68
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.68
FBXW7 modulates stress response by post-translational modification of HSF1 2.66
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 2.66
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 2.66
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.65
RNA-seq of cancer cell lines treated with T-025 2.62
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.61
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 2.6
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 2.59
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 2.59
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 2.55
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 2.54
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.52
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 2.52
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 2.51
PRDM1 inhibits proliferation of human colon cancer organoids 2.5
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.49
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.49
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.48
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 2.46
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.43
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 2.43
RNA-seq of Single-Cell Genotyping of Transcriptomes 2.41
Single-Cell Genotyping of Transcriptomes 2.41
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.38
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.38
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.37
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.37
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.37
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 2.36
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.36
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.36
Discovering human diabetes-risk gene function with genetics and physiological assays 2.35
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.33
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.32
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.3
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 2.29
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 2.29
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.29
LncRNA expression profiling of ischemic stroke patients 2.26
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.25
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.25
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.24
Identification of HOXB13 target genes responsive to BET inhibitors 2.24
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.24
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.24
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.2
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.2
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.2
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 2.2
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 2.18
SLIGRL-induced gene expression changes in NHEK cells 2.16
Effect of drugs on transcriptomic profiles 2.15
Transcriptome of activated human and mouse MAIT cells 2.12
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 2.11
Functional significance of the HIV-1 Tat signature amino acid residues 2.11
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.1
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 2.1
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 2.08
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.07
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 2.07
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.04
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.04
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.01
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 2.01
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 2.01
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.0
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 1.98
RNA sequencing of human mammary epithelial cells 1.98
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.98
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 1.98
Cajal bodies are linked to genome conformation 1.98
Cajal bodies are linked to genome conformation [RNA-Seq] 1.98
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.97
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.96
The Genetic Landscape of Diamond-Blackfan Anemia 1.95
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.93
Lysine benzoylation is a novel histone mark [RNA-seq] 1.92
Lysine benzoylation is a novel histone mark 1.92
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.91
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.91
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.89
Transcriptional profiling of LS1034 cells treated with tepoxalin 1.85
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 1.85
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.84
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.83
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.81
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.79
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.79
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.72
Real-time observation of light-controlled transcription in living cells 1.71
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.71
U2AF1 mutations alter splice site recognition in hematological malignancies 1.71
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 1.7
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.69
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.68
Controlling for gene expression changes in transcription factor protein networks. 1.68
Transcriptional landscape changes during human embryonic stem cell derivation 1.65
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 1.64
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 1.59
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.57
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.55
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.55
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.53
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.53
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 1.53
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.52
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.5
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.49
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 1.48
Ribosome profiling upon inhibition of eIF4A 1.47
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.47
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.46
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.46
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.46
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.45
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 1.44
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.43
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 1.43
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.41
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.41
Human Treg NaCl stimulation 1.4
RNA seq comparison between scrambled and shGRP78 cells 1.4
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 1.39
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 1.39
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 1.39
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 1.36
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.36
Transcriptome analysis of CNS leukemia 1.34
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 1.34
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.34
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.33
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 1.33
m6A-dependent regulation of messenger RNA stability 1.3
p53 activity results in DNA replication fork processivity 1.3
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.3
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.29
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.28
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.28
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.26
Effect of PRDM11 depletion in U2932 cells 1.25
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.24
Identification of a LIF-responsive replication-competent human β cell 1.24
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.23
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.23
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.23
Human Treg IL-12 stimulation 1.19
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.16
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.16
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.16
Impact on erythroid progenitor type on erythroid differntiation 1.15
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.15
The cohesin complex prevents Myc-induced replication stress 1.15
Identification of global XBP1s target gene expression in human prostate cancer cells 1.1
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.08
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.07
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.06
RNA-Seq of PRMT1 overexpression ECA109 cells 1.05
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 1.05
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.95
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.94
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.94
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.92
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.9
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.9
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.87
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 0.87
RNA-Seq from human ILC transitional populations 0.86
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.86
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.86
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.85
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.84
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.83
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 0.82
The contribution of Alu exons to the human proteome 0.82
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 0.81
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.8
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.8
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 0.78
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.76
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.75
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.72
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 0.7
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.69
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.69
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.69
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 0.68
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 0.67
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.66
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.65
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 0.65
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 0.65
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.65
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.64
Transcriptome-wide modulation of splicing by the exon junction complex 0.63
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.62
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.61
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.61
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.6
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.59
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.58
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.58
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.57
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.56
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.56
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.56
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 0.56
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.55
Modulation of nonsense-mediated decay by rapamycin 0.55
Primary Human B-cell Temporal Response to CD40L Stimulation 0.54
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.52
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.52
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.51
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.5
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.5
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.49
siRNA-mediated knockdown 0.47
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.46
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.46
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.44
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.43
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.42
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.4
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.4
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.39
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.38
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.38
The transcriptome and chromatin accessbility landscape of mammalian germline 0.38
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.38
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.37
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.37
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.36
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.36
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 0.36
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 0.34
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.33
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.33
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.32
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.31
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.31
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.28
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.28
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.28
Loss of CREBBP results in gene expression repression in lymphoma cells 0.28
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.26
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.24
HBEC-shp53-PCHD7 0.24
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.24
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.24
Oncogenic roles of ARID5B in T-ALL 0.21
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.21
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.2
RNA-seq data 0.2
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.19
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.17
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.17
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.17
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.16
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.16
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.16
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.15
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.13
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.13
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.13
Human Treg IFNg/IL-10 subpopulations 0.13
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.12
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.11
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.11
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.11
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.09
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.09
Global transcriptome analysis of WT versus HEB-/- hESCs 0.09
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.08
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.08
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.08
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.05
Genome-wide analysis of the Integrator complex (HTS) 0.04
Genome-wide analysis of the Integrator complex 0.04
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.03
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.03
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.02
High-resolution comparative analysis of great ape genomes 0.01
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation